Transfusion rates are up for renal patients

04/8/2013 | Renal and Urology News

More dialysis patients are receiving red blood cell transfusions following changes in the labeling of erythropoiesis-stimulating agents and new Medicare reimbursement practices involving end-stage renal disease, according to a study presented at a clinical meeting of the National Kidney Foundation. Researchers reviewed data on 42,790 dialysis patients and found an overall increase from 2007 to 2012. The rise has been steeper among Medicare beneficiaries than among those with private insurance since the 2011 reimbursement change.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY